| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 3 |
| 1 | METHYLPREDNISOLONE SODIUM SUCCINATE | 3 |
| 2 | RITUXIMAB | 2 |
| 3 | VEDOLIZUMAB | 2 |
| 4 | ACETAMINOPHEN | 1 |
| 5 | ACETAMINOPHEN 500MG | 1 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 7 | ADALIMUMAB | 1 |
| 8 | CEFTRIAXONE | 1 |
| 9 | CEFTRIAXONE SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 1 | 0.0001 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 2 | VIGABATRIN | 1 | 0.0001 |
| 3 | METHYLPREDNISOLONE SODIUM SUCCINATE | 3 | 0.0001 |
| 4 | RIFAXIMIN | 1 | 0.0000 |
| 5 | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | 1 | 0.0000 |
| 6 | CEFTRIAXONE SODIUM | 1 | 0.0000 |
| 7 | VEDOLIZUMAB | 2 | 0.0000 |
| 8 | METHYLPREDNISOLONE | 3 | 0.0000 |
| 9 | METRONIDAZOLE TOPICAL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 8 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 1 | 0.0000 |